- Home
- RVMD vs HPQ Comparison
RVMD vs HPQ Comparison
Compare RVMD & HPQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RVMD | HPQ |
|---|---|---|
| Founded | 2014 | 1939 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Manufacturing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.1B | 27.9B |
| IPO Year | 2020 | 2002 |
Fundamental Metrics
Financial Performance| Metric | RVMD | HPQ |
|---|---|---|
| Price | $190.67 | $34.37 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 19 | 12 |
| Target Price | ★ $140.84 | $21.42 |
| AVG Volume (30 Days) | 1.6M | ★ 15.8M |
| Earning Date | 05-06-2026 | 05-27-2026 |
| Dividend Yield | N/A | ★ 5.96% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 1.79 |
| Revenue | N/A | ★ $55,295,000,000.00 |
| Revenue This Year | N/A | $3.10 |
| Revenue Next Year | $533.02 | $0.39 |
| P/E Ratio | ★ N/A | $19.36 |
| Revenue Growth | N/A | ★ 3.24 |
| 52 Week Low | $42.18 | $17.56 |
| 52 Week High | $224.31 | $36.23 |
Technical Indicators
Market Signals| Indicator | RVMD | HPQ |
|---|---|---|
| Relative Strength Index (RSI) | 34.73 | 61.72 |
| Support Level | $177.04 | $18.30 |
| Resistance Level | $194.19 | $36.23 |
| Average True Range (ATR) | 7.15 | 1.63 |
| MACD | -2.74 | 0.10 |
| Stochastic Oscillator | 6.27 | 72.25 |
Price Performance
Historical ComparisonAbout RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.
About HPQ HP Inc.
HP (formerly Hewlett-Packard) is a behemoth in the PC and printing markets. It has focused on these markets since it exited IT infrastructure in 2015 with the split from Hewlett Packard Enterprise. HP focuses on the commercial market, but maintains sales of consumer devices and printers. The firm has a broad and global customer base, with only one third of sales coming from the US. HP completely outsources manufacturing and relies heavily on channel partners for its sales and marketing.